• Increase font size
  • Default font size
  • Decrease font size
home | about us | contact us
Search
Search Only:

Search Keyword extreme

Total: 50 results found.

... treatment makes matters even worse. The Haitian people are extremely resilient, and they will overcome this terrible tragedy as they have done so many times in their history. Advanced wound dressings ...
... left untreated. “Based on our research findings, biologic grafts are extremely effective when treating inguinal hernias,” said Dr. Ansaloni, a general surgeon at St. Orsola-Malpighi University ...
... dose-related immune response specific to the antigens targeted by the vaccine. “We are extremely pleased with the safety and tolerability profile of VGX-3100. Furthermore, analyses of the vaccinated ...
... industry’s first 100% natural all-in-one oral care probiotic mint, EvoraPlusTM gently whitens teeth and alleviates bad breath while supporting gum and tooth health. “We are extremely delighted to join ...
... vaccine. “We are extremely pleased with the safety and tolerability profile of VGX-3100. Furthermore, analyses of the vaccinated subjects from the first two cohorts indicate that this vaccine is highly ...
... exciting and novel tubulin inhibitor with a pharmacokinetic profile that appears extremely promising. We are enthusiastic about being the lead center for this new endeavor.” “Taxanes are the most widely ...
... testing where most VHFs are endemic. "We are extremely pleased to be part of this expanded collaboration and to have received the NIH contract," said Douglass ...
... morbidity and mortality caused by malaria, by improving the quality of the medicines used to treat this disease." "Although alarming, this study offers extremely ...
... are extremely delighted to join with Walgreens to bring EvoraPlusTM to the public. One of the country’s most outstanding retailers, Walgreens is dedicated to providing its customers with the highest ...
... are extremely delighted to join with Walgreens to bring EvoraPlusTM to the public. One of the country’s most outstanding retailers, Walgreens is dedicated to providing its customers with the highest ...
... vaccine. “We are extremely pleased with the safety and tolerability profile of VGX-3100. Furthermore, analyses of the vaccinated subjects from the first two cohorts indicate that this vaccine ...
... a pharmacokinetic profile that appears extremely promising. We are enthusiastic about being the lead center for this new endeavor.” “Taxanes are the most widely used drug class in oncology,” ...
...  States during its second fiscal quarter with a full release expected during the company’s fiscal third quarter. “We are extremely pleased to receive FDA marketing clearance for the Flow ...
... exciting and novel tubulin inhibitor with a pharmacokinetic profile that appears extremely promising. We are enthusiastic about being the lead center for this new endeavor.” “Taxanes are the most widely ...
... Advisory Committee (ODAC) public advisory meeting scheduled for 10 February 2010 has been suspended due to extreme weather conditions in Washington D.C. The ODAC meeting was scheduled to review ...
... vaccine. “We are extremely pleased with the safety and tolerability profile of VGX-3100. Furthermore, analyses of the vaccinated subjects from the first two cohorts indicate that this vaccine is highly ...
... that their “...study design has several limitations, but that the results are encouraging and warrant a randomized controlled clinical trial.” He also stated that it is “...extremely rewarding to provide ...
... makers. As the official Media Partner, MedicExchange.com will conduct special TV interviews with guest speakers and exhibitors. MedicExchange.com CEO, Alex van Klaveren, says: "We are extremely excited ...
... good charge times or longevity. I especially like the six months longevity post-ERI and the PARAD+ discrimination algorithm to minimize inappropriate shocks…that is extremely important to both my patients ...
... of Miami Ryder Trauma Center, reported that initial resuscitation with Hextend was associated with no obvious coagulopathy and reduced mortality compared to fluid resuscitation without Hextend. “...extremely ...
... is extremely important to both my patients and myself.” Paradym™ CRT is designed to allow more flexibility in the management of cardiac resynchronization and anti-tachyarrhythmia therapy ...
... indicating extremely high antibacterial efficacy for its novel technology (6-7.2 log reductions) against the primary causative agents of hospital acquired infections (HAIs), sometimes referred to as "Super ...
... and ranks among the top of the industry in terms of quality, performance, accuracy, and repeatability.Omron's mass flow chip is extremely sensitive -- enough to be able to detect the air displaced by the ...
... fully automated platform, now in prototype phase, ensures extremely fast and reproducible results, even in the hands of inexperienced users. This serves not only to reduce experimental errors commonly ...
... in their strategic planning and ability to execute, evidenced in part by their capital-raising success and the submission of the ANX-530 NDA, all during extremely difficult times."   About ...
... financing was co-led by Hatteras Venture Partners and Intersouth Partners. LabCorp also is participating in the financing as an equity investor. “Cancer is an extremely complex disease that ...
... proven market solutions." "We are extremely excited to share combined communication tools that will have a positive impact on our clients and their target ...
... examination of data collected from 43 surgical critical care patients showed no relationship between IVC and blood volume. These studies are extremely important as they demonstrate that three commonly ...
... countries. The molecule is also extremely resistant to heat, which will enable it to be distributed and used in the tropics without refrigeration. "We are grateful to the Wellcome Trust for its support ...
... ) "We are extremely pleased that the Wellcome Trust Sanger Institute, as a world leading genome center, has determined that our reagents meet their high standards," ...
... Mary A. Carter, site administrator with MHC. "We are extremely excited that they will be treating patients in Marana." Marana Healthcare Clinic functions ...
... by enabling far more accurate prediction of potential drug indications, interactions and side effects. “Access to equity investment is extremely important for innovative Scottish companies like Sistemic, ...
... will be circa 4,000,000 usd. 10. The numbers are related only for the USA market. We do supply for many other countries also. Mr. Shoham commented, "We are extremely pleased with the acceptance of ...
... the largest network marketing company in Japan. We are extremely pleased that they have decided to market AC-11®-melon and that they recognize the importance of combining synergistic ingredients for ...
... opportunities in front of us, we are extremely pleased that the cash injection will help us to broaden our product range and to ramp up our sales and marketing efforts." EUCODIS ...
... Galakatos, Ph.D., Managing Director of Clarus Ventures and member of the NanoString Board of Directors. “His leadership, domain expertise, and strategic thinking will be extremely valuable for ...
... with his new roles taking effect immediately. “We are extremely pleased to have Jordan join us as both COO and our newest Board member” “We are extremely pleased to have Jordan join us as both COO ...
... sales of its recently launched over-the-counter pain reliever, Cobroxin, totaled $583,955 for the fourth quarter ending December 31, 2009. “We were extremely pleased with our fourth quarter Cobroxin ...
... consumers and retailers, we remain optimistic about the future growth of Cobroxin as we move into 2010” “We were extremely pleased with our fourth quarter Cobroxin sales, especially given its initial ...
... targeting the B7 family of co-stimulatory molecules that have been published to date.” Compugen’s VP R&D, Dr. Zurit Levine stated, “We are extremely pleased by this further demonstration of the unique ...
...  from Cobroxin consumers and retailers, we remain optimistic about the future growth of Cobroxin as we move into 2010” “We were extremely pleased with our fourth quarter Cobroxin sales, ...
... about the impact of issues on the industry's ability to keep biomedical research, innovation and investment in California, respondents ranked the following as extremely important: corporate taxation (72 ...
... medtech companies continue to face extreme competition for a restricted amount of available capital funding. This makes Medical Device Investor Day the perfect venue for emerging companies to meet and ...
... enables comprehensive identification and measurement of chemicals at extremely low amounts. The specific technology that comprises this solution consists of six AB SCIEX 3200 QTRAP® systems. The ...
...  market expansion is extremely important to our overall strategy. Wondfo will be selling private label cardiac products, while O&D sells co-branded RAMP® products on both the RAMP® and ...
... these companies.” “We’re extremely proud to represent these important vendor partnerships in such a visible and relevant way for everyday shoppers,” said Glispie. “This ...
... patch will reduce drug abuse, makes it extremely attractive commercially,” said Dr Esra Ogru, Phosphagenics’ Chief Operating Officer. “The continued increase in oxycodone concentrations ...
... through its subsidiary, Upstate Pharma. "UCB is extremely grateful to our entire U.S. primary care team. Their hard work and dedication for more than a decade laid a strong foundation for UCB's future ...
...  of their products without compromising on taste. Senomyx is looking forward to working with Firmenich as they begin pre-commercial activities.” “Senomyx is extremely pleased that after a thorough ...
... and technologies based on the company's exclusive collection of microorganisms from extreme environments. ZyGEM's technology has significant competitive advantages over existing methods and has potential ...

Sign Up For Phone Alerts

Home | Privacy Policy
© 2010 BioMedReports.com. All rights reserved